ZACROS Corporation
Stock Price Chart
2026/08/07 UpdatedPrice Trend
2026/08/07 UpdatedPrice & Trading Details
2026/08/07 UpdatedPRICE
TRADING
Analyst Recommendations 1 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2024/02/06 | ¥16.68 | ¥-4.00 | -124.0% |
| 2023/11/07 | ¥18.08 | ¥19.93 | +10.3% |
| 2023/08/03 | ¥9.03 | ¥25.94 | +187.4% |
| 2023/05/10 | ¥-5.77 | ¥5.68 | +198.3% |
Shareholder Composition
Updated 2026/08/01Dividend History
Updated 2026/08/02| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥18 | -48.2% |
| 2025 | ¥35 | +32.4% |
| 2024 | ¥26 | +25.0% |
| 2023 | ¥21 | 0.0% |
| 2022 | ¥21 | - |
Financial Performance
2026/08/02 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥129,364M | ¥136,155M | ¥150,735M | ¥158,535M |
| Gross Profit | ¥25,711M | ¥29,744M | ¥34,735M | ¥36,807M |
| Operating Income | ¥5,883M | ¥8,344M | ¥10,117M | ¥11,054M |
| Pretax Income | ¥7,689M | ¥7,296M | ¥9,749M | ¥11,670M |
| Net Income | ¥4,854M | ¥4,532M | ¥6,530M | ¥7,707M |
| EPS | ¥63.27 | ¥59.79 | ¥348.00 | ¥105.13 |
| Operating Margin | 4.55% | 6.13% | 6.71% | 6.97% |
| Balance Sheet | ||||
| Total Assets | ¥128,440M | ¥141,680M | ¥153,926M | ¥156,791M |
| Total Equity | ¥82,449M | ¥85,957M | ¥92,000M | ¥95,196M |
| Total Liabilities | ¥45,991M | ¥55,723M | ¥61,926M | ¥61,595M |
| Cash | ¥11,232M | ¥15,516M | ¥14,986M | ¥14,844M |
| Interest-bearing Debt | ¥1,987M | ¥1,654M | ¥6,004M | ¥12,326M |
| Equity Ratio | 64.19% | 60.67% | 59.77% | 60.72% |
| D/E Ratio | 0.02 | 0.02 | 0.07 | 0.13 |
| Cash Flow | ||||
| Operating CF | ¥8,365M | ¥10,083M | ¥6,588M | ¥11,781M |
| Investing CF | -¥3,966M | -¥6,109M | -¥17,462M | -¥20,069M |
| Financing CF | -¥2,445M | -¥3,507M | ¥269M | ¥191M |
| Free CF | ¥3,233M | ¥3,145M | -¥11,517M | -¥9,990M |
| Efficiency | ||||
| ROE | 5.89% | 5.27% | 7.10% | 8.10% |
| ROA | 3.78% | 3.20% | 4.24% | 4.92% |
Latest IR Information
-
FY2026 1Q Financial Summary Supplement
FY2026 1Q discloses trends in revenue, operating income, ordinary income, and net income attributable to owners of the parent. Confirms segment contributions and whether full-year forecasts were revised.
Read more -
2027年３月期 第１四半期決算短信〔日本基準〕（連結）
For the first quarter of the fiscal year ending March 2027, consolidated results show net sales of 41,420 million yen (YoY +5.4%), operating income of 3,359 million yen (△2.9%), ordinary income of 3,438 million yen (△4.6%), and net income attributable...
Read more -
Notice on Share Buyback as Restricted Stock
Resolved to allocate restricted stock to directors and voluntary executive officers as treasury stock disposal. Number of allocated shares: 3 directors × 19,400 shares, 4 voluntary executive officers × 19,500 shares, total 38,900 shares. Paid-in price is 1,303 yen per...
Read more -
Notice Regarding Share Buyback Status and Termination
Under the share buyback framework, 163,400 shares were acquired at a total amount of 201,934,600 yen. Acquisition period: 2026/06/01-2026/06/30 (settlement-based), market purchases. The buyback is now terminated. Going forward, the company will continue to balance shareholder returns with growth investments.
Read more -
[Z A C R O S] Notice of Executive Changes and Restructuring | June 2026
At the shareholders' meeting held on June 19, 2026, 8 directors and 3 directors who are Audit & Supervisory Committee members were elected, and details of the officer changes and biographies of newly appointed officers were also announced.
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥1,900
Rating Score: 2.00 (Based on 1 analysts)
※1=Strong Buy, 5=Strong Sell
ZACROS lifts sales and profit as it expands footprint, keeps full-year forecast intact - TipRanks ↗
The - holdings.toppan.com ↗
Company Information
About
ZACROS Corporation manufactures and sells products for wellness environmental solutions, information electronic, and industrial infrastructure in Japan and internationally. It operates through four segments: Wellness Business; Environmental Solutions Business; Information and Electronics Business; and Industrial Infrastructure Business. The company offers wellness products, including MediTect IV Bag, a non-adsorbing, low-leaching packaging for ready-to-use (RTU) drugs; BioPhas, a customized service that is used in single-use products for biopharmaceuticals manufacturing; and Total Thrombus-formation Analysis System, a flow chamber system. It also provides environmental solutions, such as flexible refill pouches; liquid containers; and high performance / high clean packaging. In addition, the company offers protective films; coating commissioned processing services; and free standing electrode, as well as adhesive films, release liners, tab seal film, and industrial laminate film. Further, it engages in industrial infrastructure activities. The company was formerly known as Fujimori Kogyo Co., Ltd. and changed its name to ZACROS Corporation in October 2024. ZACROS Corporation was founded in 1914 and is headquartered in Bunkyo, Japan.
